| Jackie Curl, CRNFA | |
|
7120 Sw 9th Ave, Amarillo, TX 79106-1704 | |
| (806) 463-2251 | |
| (806) 463-2252 |
| Full Name | Jackie Curl |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Medical-surgical |
| Location | 7120 Sw 9th Ave, Amarillo, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336173913 | NPI | - | NPPES |
| 0006HT | Other | TX | BLUE CROSS & BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SM0705X | Clinical Nurse Specialist - Medical-surgical | 525114 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jackie Curl, CRNFA Po Box 51440, Amarillo, TX 79159-1440 Ph: (806) 355-9595 | Jackie Curl, CRNFA 7120 Sw 9th Ave, Amarillo, TX 79106-1704 Ph: (806) 463-2251 |
News Archive
Researchers at the Technion-Israel Institute of Technology have made a breakthrough that could lead to radical changes in the design and effectiveness of inhalation masks for infants.
A growing number of registered nurses (RNs) and nurse practitioners (NPs) are working in positions of first point of contact between patients and the health-care system, helping improve patient access to primary care and driving down wait times.
Shire plc, the global specialty biopharmaceutical company, today announced that the European Commission has approved FIRAZYR for self-administration after training in subcutaneous injection technique by a healthcare professional. FIRAZYR is the first and only treatment for acute Type I and Type II hereditary angioedema (HAE) attacks licensed for self-administration in Europe.
Sanofi announced today that Lyxumia (lixisenatide), a once-daily GLP-1 receptor agonist under development for type 2 diabetes, achieved its primary efficacy endpoint of significant HbA1c reduction vs. placebo in patients uncontrolled on metformin.
CSL Behring today announced it has enrolled the first patient in COMPACT, an international phase III study of a volume-reduced, subcutaneous formulation of C1-esterase inhibitor oncentrate in patients with frequent hereditary angioedema attacks (NCT01912456).
› Verified 7 days ago
Blanca Rangel, APRN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1411 E Amarillo Blvd, Amarillo, TX 79107 Phone: 806-351-7510 | |
Mrs. Elizabeth G Blodgett, FNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 3440 Bell St Unit 122, Amarillo, TX 79109 Phone: 806-379-9225 Fax: 806-331-4497 | |
Vina L De La O-turner, NP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 6601 W I 40 Ste 300, Amarillo, TX 79106 Phone: 806-331-7905 Fax: 806-731-1516 | |
Shelby Fields, AGACNP-BC Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1400 S Coulter St, Amarillo, TX 79106 Phone: 806-414-9558 | |
Tamara Lyn Jarrous, ACNS-BC Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1901 Medi Park Dr Ste 2058, Amarillo, TX 79106 Phone: 806-354-9540 Fax: 806-354-9588 | |
Dr. Virginia Rodgers Sicola, RN,AOCN,CS, PHD Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 6010 W Amarillo Blvd, Amarillo, TX 79106 Phone: 806-354-7871 |